← Back to Search

Non-invasive Brain Stimulation

TMS for Autism Spectrum Disorder (TMSinASD Trial)

N/A
Waitlist Available
Research Sponsored by Yale University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up measures will be recorded for the duration of their visit, an expected average of 4-5hrs
Awards & highlights

TMSinASD Trial Summary

This trial will study the effects of a common brain stimulation technique, called TMS, on social cognition in people with ASD. The trial will include assessments of cognitive and behavioral function, as well as measures of brain activity and eye movement, before and after TMS.

Who is the study for?
This trial is for individuals aged 18-40 with either typical development or a diagnosis of Autism Spectrum Disorder (ASD). They must be able to undergo EEG and eye-tracking tests. It's not suitable for those with serious brain issues, major psychiatric illnesses, medical conditions like stroke or seizures, recent drug/alcohol use, pregnant women, or anyone with metal in their body.Check my eligibility
What is being tested?
The study is testing the impact of repetitive Transcranial Magnetic Stimulation (rTMS) on how people with ASD process social information. This involves looking at changes in brain activity and behavior before and after TMS using EEGs and eye-tracking technology.See study design
What are the potential side effects?
While rTMS is generally considered safe, potential side effects may include discomfort at the stimulation site, headache, lightheadedness, or tingling. There's also a very low risk of seizure.

TMSinASD Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~measures will be recorded for the duration of their visit, an expected average of 4-5hrs
This trial's timeline: 3 weeks for screening, Varies for treatment, and measures will be recorded for the duration of their visit, an expected average of 4-5hrs for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
right lateralized N170 latency to upright faces
Secondary outcome measures
The Benton Face Recognition Task
proportion of visual attention to the eye region of the face

TMSinASD Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Transcranial Magnetic Stimulation - realActive Control1 Intervention
Participants will receive active TMS during their study visit
Group II: Transcranial Magnetic Stimulation - shamPlacebo Group1 Intervention
Participants will receive sham stimulation during their study visit simulating TMS

Find a Location

Who is running the clinical trial?

Yale UniversityLead Sponsor
1,847 Previous Clinical Trials
2,736,428 Total Patients Enrolled
26 Trials studying Autism Spectrum Disorder
2,287 Patients Enrolled for Autism Spectrum Disorder

Media Library

TMS (Non-invasive Brain Stimulation) Clinical Trial Eligibility Overview. Trial Name: NCT04242355 — N/A
Autism Spectrum Disorder Research Study Groups: Transcranial Magnetic Stimulation - real, Transcranial Magnetic Stimulation - sham
Autism Spectrum Disorder Clinical Trial 2023: TMS Highlights & Side Effects. Trial Name: NCT04242355 — N/A
TMS (Non-invasive Brain Stimulation) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04242355 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this clinical trial accept elderly participants aged 80 and above?

"This trial is seeking participants who have attained the age of majority but are younger than 40 years old."

Answered by AI
Recent research and studies
Journal of Child Psychology and PsychiatryJournal
Event-related Brain Potentials Reveal Anomalies in Temporal Processing of Faces in Autism Spectrum Disorder
McPartland, James, Geraldine Dawson, Sara J. Webb, Heracles Panagiotides, and Leslie J. Carver. 2004. “Event-related Brain Potentials Reveal Anomalies in Temporal Processing of Faces in Autism Spectrum Disorder”. Journal of Child Psychology and Psychiatry. Wiley. doi:10.1111/j.1469-7610.2004.00318.x.
Journal of Autism and Developmental DisordersJournal
Use of Transcranial Magnetic Stimulation in Autism Spectrum Disorders
Oberman, Lindsay M., Alexander Rotenberg, and Alvaro Pascual-Leone. 2013. “Use of Transcranial Magnetic Stimulation in Autism Spectrum Disorders”. Journal of Autism and Developmental Disorders. Springer Science and Business Media LLC. doi:10.1007/s10803-013-1960-2.
Frontiers in NeuroscienceJournal
The Impact of Single Session Intermittent Theta-burst Stimulation over the Dorsolateral Prefrontal Cortex and Posterior Superior Temporal Sulcus on Adults with Autism Spectrum Disorder
Ni, Hsing-Chang, June Hung, Chen-Te Wu, Yu-Yu Wu, Chee-Jen Chang, Rou-Shayn Chen, and Ying-Zu Huang. 2017. “The Impact of Single Session Intermittent Theta-burst Stimulation over the Dorsolateral Prefrontal Cortex and Posterior Superior Temporal Sulcus on Adults with Autism Spectrum Disorder”. Frontiers in Neuroscience. Frontiers Media SA. doi:10.3389/fnins.2017.00255.
Clinical NeurophysiologyJournal
Safety, Ethical Considerations, and Application Guidelines for the Use of Transcranial Magnetic Stimulation in Clinical Practice and Research
Rossi, Simone, Mark Hallett, Paolo M. Rossini, and Alvaro Pascual-Leone. 2009. “Safety, Ethical Considerations, and Application Guidelines for the Use of Transcranial Magnetic Stimulation in Clinical Practice and Research”. Clinical Neurophysiology. Elsevier BV. doi:10.1016/j.clinph.2009.08.016.
All > Asd > Transcranial Magnetic Stimulation
~3 spots leftby Jul 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top